ArticleDermatology and therapy2025

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis).

Mario Valenti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.